Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06704113 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2024 (before its estimated January 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.
Trial Details
NCT Number NCT06704113
Lead Sponsor Universidad Austral de Chile
Conditions
(from sponsor)		 Dental Pain, Sensation Disorders
Related terms Sensation Disorders, Toothache
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov